abstract |
PROBLEM TO BE SOLVED: To provide an effective means for treating female sexual dysfunction (FSD), particularly female with female sexual arousal disorder (FSAD). The present invention provides a method for assaying agents capable of enhancing cAMP in the female genital tract, particularly female sexual dysfunction associated with female sexual arousal disorder. The agent of the present invention is a neuropeptide Y inhibitor (I: NPY). The present invention also provides a method and kit for detecting female sexual dysfunction, particularly female sexual arousal disorder. Furthermore, the present invention identifies drugs that can treat female sexual dysfunction, particularly female sexual arousal disorders, including anesthetized female animals that include means for measuring changes in animal genital blood flow following pelvic nerve stimulation. A non-human animal model for use in is also provided. [Selection figure] None |